Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 644 Thousand USD | -18.17% |
| 2022 | 787 Thousand USD | 50.77% |
| 2021 | 522 Thousand USD | -21.03% |
| 2020 | 661 Thousand USD | -55.82% |
| 2019 | 1.49 Million USD | 212.97% |
| 2018 | 478 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 135 Thousand USD | 0.75% |
| 2024 Q2 | 182 Thousand USD | 34.81% |
| 2023 Q2 | 256 Thousand USD | 130.63% |
| 2023 Q1 | 111 Thousand USD | -60.64% |
| 2023 Q4 | 134 Thousand USD | -6.29% |
| 2023 Q3 | 143 Thousand USD | -44.14% |
| 2023 FY | 644 Thousand USD | -18.17% |
| 2022 Q3 | 196 Thousand USD | 64.71% |
| 2022 Q1 | 190 Thousand USD | -26.36% |
| 2022 Q4 | 282 Thousand USD | 43.88% |
| 2022 FY | 787 Thousand USD | 50.77% |
| 2022 Q2 | 119 Thousand USD | -37.37% |
| 2021 Q3 | 109 Thousand USD | 53.52% |
| 2021 FY | 522 Thousand USD | -21.03% |
| 2021 Q1 | 84 Thousand USD | -56.02% |
| 2021 Q2 | 71 Thousand USD | -15.48% |
| 2021 Q4 | 258 Thousand USD | 136.7% |
| 2020 Q4 | 191 Thousand USD | 45.8% |
| 2020 Q1 | 207 Thousand USD | 36.18% |
| 2020 Q2 | 133 Thousand USD | -35.75% |
| 2020 Q3 | 131 Thousand USD | -1.5% |
| 2020 FY | 661 Thousand USD | -55.82% |
| 2019 Q1 | 677 Thousand USD | 41.63% |
| 2019 FY | 1.49 Million USD | 212.97% |
| 2019 Q4 | 152 Thousand USD | 1.33% |
| 2019 Q3 | 150 Thousand USD | -71.04% |
| 2019 Q2 | 518 Thousand USD | -23.49% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | 478 Thousand USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 478 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 94.66% |
| BrainsWay Ltd. | 31.78 Million USD | 97.974% |
| Cerus Corporation | 156.36 Million USD | 99.588% |
| Envoy Medical, Inc. | 316 Thousand USD | -103.797% |
| electroCore, Inc. | 16.03 Million USD | 95.983% |
| IceCure Medical Ltd | 3.22 Million USD | 80.056% |
| Inogen, Inc. | 315.66 Million USD | 99.796% |
| OrthoPediatrics Corp. | 148.73 Million USD | 99.567% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 73.476% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -76.439% |
| MaxCyte, Inc. | 41.28 Million USD | 98.44% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 67.016% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -481.5% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.914% |
| PAVmed Inc | 2.45 Million USD | 73.736% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 97.14% |
| RxSight, Inc. | 89.07 Million USD | 99.277% |
| Sight Sciences, Inc. | 81.05 Million USD | 99.205% |
| SI-BONE, Inc. | 138.88 Million USD | 99.536% |
| TELA Bio, Inc. | 58.45 Million USD | 98.898% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 99.656% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 95.334% |
| Acutus Medical, Inc. | 7.16 Million USD | 91.011% |
| Talis Biomedical Corporation | 412 Thousand USD | -56.311% |
| Spectral AI, Inc. | 18.05 Million USD | 96.433% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 93.498% |
| CVRx, Inc. | 39.29 Million USD | 98.361% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | 33.52% |
| Bioventus Inc. | 512.34 Million USD | 99.874% |
| Venus Concept Inc. | 76.35 Million USD | 99.157% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 96.521% |
| LivaNova PLC | 1.15 Billion USD | 99.944% |
| 908 Devices Inc. | 50.22 Million USD | 98.718% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.866% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -735.886% |
| NeuroPace, Inc. | 65.42 Million USD | 99.016% |
| LENSAR, Inc. | 42.16 Million USD | 98.473% |
| Apyx Medical Corporation | 52.34 Million USD | 98.77% |
| Cutera, Inc. | 212.36 Million USD | 99.697% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 98.069% |
| BioSig Technologies, Inc. | 18 Thousand USD | -3477.778% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 99.614% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 97.312% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.958% |
| Axonics, Inc. | 366.37 Million USD | 99.824% |
| Outset Medical, Inc. | 130.37 Million USD | 99.506% |
| IRIDEX Corporation | 51.86 Million USD | 98.758% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.527% |
| IRadimed Corporation | 65.56 Million USD | 99.018% |
| Tivic Health Systems, Inc. | 1.17 Million USD | 45.238% |
| INVO Bioscience, Inc. | 3.02 Million USD | 78.68% |
| Telesis Bio, Inc. | 27.5 Million USD | 97.659% |
| Viemed Healthcare, Inc. | 183 Million USD | 99.648% |
| Varex Imaging Corporation | 811 Million USD | 99.921% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.71% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 99.062% |
| Dynatronics Corporation | 32.53 Million USD | 98.021% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 92.579% |
| Semler Scientific, Inc. | 68.18 Million USD | 99.055% |
| InMode Ltd. | 492.04 Million USD | 99.869% |
| Bruker Corporation | 2.96 Billion USD | 99.978% |
| Cytosorbents Corporation | 36.34 Million USD | 98.228% |
| DexCom, Inc. | 3.62 Billion USD | 99.982% |
| Align Technology, Inc. | 3.86 Billion USD | 99.983% |
| Viveve Medical, Inc. | 6.42 Million USD | 89.978% |
| ZimVie Inc. | 457.43 Million USD | 99.859% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 99.666% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -481.5% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.914% |
| Profound Medical Corp. | 7.33 Million USD | 91.215% |
| Insulet Corporation | 1.69 Billion USD | 99.962% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 99.489% |
| iCAD, Inc. | 17.31 Million USD | 96.281% |
| Nuwellis, Inc. | 8.86 Million USD | 92.735% |
| Biotricity, Inc. | 12.06 Million USD | 94.662% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.869% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 89.621% |
| PAVmed Inc. | 2.45 Million USD | 73.736% |
| BIOLASE, Inc. | 49.16 Million USD | 98.69% |
| Beyond Air, Inc. | 1.15 Million USD | 44.435% |
| FONAR Corporation | 102.88 Million USD | 99.374% |
| AxoGen, Inc. | 159.01 Million USD | 99.595% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.765% |
| Inari Medical, Inc. | 493.63 Million USD | 99.87% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.839% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -3362.366% |
| Tenon Medical, Inc. | 2.92 Million USD | 78.005% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 90.546% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.98% |
| Sintx Technologies, Inc. | 2.62 Million USD | 75.485% |
| NanoVibronix, Inc. | 2.28 Million USD | 71.792% |
| Quanterix Corporation | 122.36 Million USD | 99.474% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 97.361% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.679% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.733% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 95.352% |
| NeuroMetrix, Inc. | 5.9 Million USD | 89.087% |
| Hyperfine, Inc. | 11.03 Million USD | 94.162% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 99.61% |
| Biomerica, Inc. | 5.41 Million USD | 88.107% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 98.726% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 99.636% |